Vaccine World East Asia 2015

Date: 13-Jan-15 to 14-Jan-15
Location: To be decided / Seoul / Korea, Republic of
Category: Conferences & Trade Fairs

The ONLY Vaccine focused gathering in East Asia!

Vaccine World Summit Series is one of the most sought after vaccine industrial gathering for developing country manufacturers, which happens every year in several countries in Asia Pacific Region.

The vaccine industry in East Asia, typically in Japan, Korea and Taiwan, has witnessed a tremendous growth over the past ten years.

East Asia’s vaccine industry will start to play a more important role on the global stage for the improvement of health, treatment of cancer and eradication of infectious diseases. Korea’s government has set ambitious targets for the growth of its vaccine industry by the end of the decade. It targets a tenfold increase in the value of exports and an increasing presence in its domestic market from 30% to 80%. Japan, on the other hand, has anticipated a high CAGR of 25.7% from 2012 – 2017 as well as various strategic partnerships and huge investments from pharmaceutical companies. In Taiwan, we see budding manufacturers joining the market with innovative portfolio such as new influenza vaccines and cancer vaccines.

If East Asia’s vaccine business matters to you, then you need to be at Vaccine East Asia 2015. The region has a unique combination of large domestic manufacturers, innovative biotechs and institutional vaccine research facilities. Vaccine World Summit is the ONLY meeting place bringing together CXOs, vaccine R&D and manufacturing leaders to discuss and debate on latest vaccine manufacturing practices, share newest product developments, form partnerships and build relationships!

Visitors

Vaccine Manufacturers, CEOs, Managing Directors, VPs & Directors of Manufacturing, Scientists & Engineers, CSOs, CTOs, VPs & Directors of R&D

Exhibitors

Vaccine Manufacturers

Go to event website

EIN News provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See: